Is histological prostate inflammation in an initial prostate biopsy a predictor of prostate cancer on repeat biopsy?

International Urology and Nephrology

Volumn 47, Issue 8, 2015, Pages 1251-1257

  Yun, Bu Hyeon ^a   Hwang, Eu Chang ^a   Yu, Ho Song ^a   Chung, Hoseok ^a   Kim, Sun Ouck ^a   Jung, Seung Il ^a   Kang, Taek won ^a   Kwon, Dong Deuk ^a   Park, Kwangsung ^a   Choi, Chan ^a  

^a Chonnam National University Medical School   (South Korea)

Author keywords

Biopsy; Inflammation; Prostatic neoplasms

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; ARTICLE; CANCER GRADING; CLINICAL EVALUATION; DISEASE ASSOCIATION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PREDICTION; PROSTATE BIOPSY; PROSTATE CANCER; PROSTATE VOLUME; PROSTATITIS; REPEAT PROCEDURE; RETROSPECTIVE STUDY; RISK ASSESSMENT; AGED; BIOPSY; COMPLICATION; DIFFERENTIAL DIAGNOSIS; DISEASE COURSE; METABOLISM; MIDDLE AGED; PATHOLOGY; PREDICTIVE VALUE; PROCEDURES; PROSTATIC NEOPLASMS; RISK FACTOR;

AGED; BIOPSY; DIAGNOSIS, DIFFERENTIAL; DISEASE PROGRESSION; HUMANS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; PROSTATITIS; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 84938293027     PISSN: 03011623     EISSN: 15732584     Source Type: Journal    
DOI: 10.1007/s11255-015-1029-6     Document Type: Article

References (30)

1. Roberts RO, Bergstralh EJ, Lieber MM, Jacobsen SJ (2000) Digital rectal examination and prostate-specific antigen abnormalities at the time of prostate biopsy and biopsy outcomes, 1980 to 1997. Urology 56:817–822
2. Littrup PJ, Bailey SE (2000) Prostate cancer: the role of transrectal ultrasound and its impact on cancer detection and management. Radiol Clin N Am 38:87–113
3. Roehl KA, Antenor JA, Catalona WJ (2002) Serial biopsy results in prostate cancer screening study. J Urol 167:2435–2439
4. Nam RK, Saskin R, Lee Y et al (2010) Increasing hospital admission rates for urological complications after transrectal ultrasound guided prostate biopsy. J Urol 183:963–968
5. Partin AW, Carter HB, Chan DW et al (1990) Prostate specific antigen in the staging of localized prostate cancer: influence of tumor differentiation, tumor volume and benign hyperplasia. J Urol 143:747–752
6. Nadler RB, Humphrey PA, Smith DS, Catalona WJ, Ratliff TL (1995) Effect of inflammation and benign prostatic hyperplasia on elevated serum prostate specific antigen levels. J Urol 154:407–413
7. Cohen RJ, Shannon BA, McNeal JE, Shannon T, Garrett KL (2005) Propionibacterium acnes associated with inflammation in radical prostatectomy specimens: a possible link to cancer evolution? J Urol 173:1969–1974
8. Nickel JC, True LD, Krieger JN, Berger RE, Boag AH, Young ID (2001) Consensus development of a histopathological classification system for chronic prostatic inflammation. BJU Int 87:797–805
9. Irani J, Levillain P, Goujon JM, Bon D, Doré B, Aubert J (1997) Inflammation in benign prostatic hyperplasia: correlation with prostate specific antigen value. J Urol 157:1301–1303
10. Fleshner NE, O’Sullivan M, Fair WR (1997) Prevalence and predictors of a positive repeat transrectal ultrasound guided needle biopsy of the prostate. J Urol 158:505–508
11. Noguchi M, Yahara J, Koga H, Nakashima O, Noda S (1999) Necessity of repeat biopsies in men for suspected prostate cancer. Int J Urol 6:7–12
12. Durkan GC, Greene DR (1999) Elevated serum prostate specific antigen levels in conjunction with an initial prostatic biopsy negative for carcinoma: who should undergo a repeat biopsy? BJU Int 83:34–38
13. Merrimen JL, Jones G, Walker D, Leung CS, Kapusta LR, Srigley JR (2009) Multifocal high grade prostatic intraepithelial neoplasia is a significant risk factor for prostatic adenocarcinoma. J Urol 182:485–490
14. Lee JG, Bae SH, Choi SH, Kwon TG, Kim TH (2012) Role of prostate-specific antigen change ratio at initial biopsy as a novel decision-making marker for repeat prostate biopsy. Korean J Urol 53:467–471
15. Catalona WJ, Partin AW, Slawin KM et al (1998) Use of the percentage of free prostate-specific antigen to enhance differentiation of prostate cancer from benign prostatic disease: a prospective multicenter clinical trial. JAMA 279:1542–1547
16. Morgan TO, McLeod DG, Leifer ES, Murphy GP, Moul JW (1996) Prospective use of free prostate-specific antigen to avoid repeat prostate biopsies in men with elevated total prostate-specific antigen. Urology 48:76–80
17. Vignozzi L, Maggi M (2014) Prostate cancer: intriguing data on inflammation and prostate cancer. Nat Rev Urol 11:369–370
18. Corona G, Vignozzi L, Rastrelli G, Lotti F, Cipriani S, Maggi M (2014) Benign prostatic hyperplasia: a new metabolic disease of the aging male and its correlation with sexual dysfunctions. Int J Endocrinol 2014:329456
19. Brawer MK, Rennels MA, Nagle RB, Schifman R, Gaines JA (1989) Serum prostate-specific antigen and prostate pathology in men having simple prostatectomy. Am J Clin Pathol 92:760–764
20. Schatteman PH, Hoekx L, Wyndaele JJ, Jeuris W, Van Marck E (2000) Inflammation in prostate biopsies of men without prostatic malignancy or clinical prostatitis: correlation with total serum PSA and PSA density. Eur Urol 37:404–412
21. Kandirali E, Boran C, Serin E, Semercioz A, Metin A (2007) Association of extent and aggressiveness of inflammation with serum PSA levels and PSA density in asymptomatic patients. Urology 70:743–747
22. Kim HW, Kim SH, Kim SW, Jung KI, Min KO, Cho SY (2009) Effects of subclinical prostatitis on benign prostatic hyperplasia. Korean J Urol 50:154–158
23. Park CH, Kim SJ, Park CM, Kim HK, Park JY (2009) The influence of prostate chronic inflammation on parameters related to prostate cancer in asymptomatic patients. Korean J Urol Oncol 7:74–81
24. Terakawa T, Miyake H, Kanomata N, Kumano M, Takenaka A, Fujisawao M (2008) Inverse association between histologic inflammation in needle biopsy specimens and prostate cancer in men with serum PSA of 10–50 ng/mL. Urology 72:1194–1197
25. Pepe P, Aragona F (2011) Does an inflammatory pattern at primary biopsy suggest a lower risk for prostate cancer at repeated saturation prostate biopsy? Urol Int 87:171–174
26. Gurel B, Lucia MS, Thompson IM Jr et al (2014) Chronic inflammation in benign prostate tissue is associated with high-grade prostate cancer in the placebo arm of the prostate cancer prevention trial. Cancer Epidemiol Biomark Prev 23:847–856
27. Fujita K, Hosomi M, Tanigawa G, Okumi M, Fushimi H, Yamaguchi S (2011) Prostatic inflammation detected in initial biopsy specimens and urinary pyuria are predictors of negative repeat prostate biopsy. J Urol 185:1722–1727
28. Moreira DM, Nickel JC, Gerber L et al (2014) Baseline prostate inflammation is associated with a reduced risk of prostate cancer in men undergoing repeat prostate biopsy: results from the REDUCE study. Cancer 120:190–196
29. Yli-Hemminki TH, Laurila M, Auvinen A et al (2013) Histological inflammation and risk of subsequent prostate cancer among men with initially elevated serum prostate-specific antigen (PSA) concentration in the Finnish prostate cancer screening trial. BJU Int 112:735–741
30. Delongchamps NB, de la Roza G, Chandan V et al (2008) Evaluation of prostatitis in autopsied prostates-is chronic inflammation more associated with benign prostatic hyperplasia or cancer? J Urol 179:1736–1740